Stocks in play: ESSA Pharma Inc.
Presented new preclinical data on ESSA's clinical candidate, EPI-7386, at the 2020 American Association for Cancer Research Virtual Annual Meeting II. ESSA Pharma Inc. shares V.EPI are trading unchanged at $7.00.
Read: